Loading...
Approach to evaluating tumor mutational burden in routine clinical practice
Immune checkpoint inhibition with monoclonal antibodies has emerged as a promising therapeutic approach but in most tumor types responses are unpredictable and observed in a minority of treated patients. Positive and negative predictive biomarkers for efficacy of these costly drugs are desperately n...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249621/ https://ncbi.nlm.nih.gov/pubmed/30505712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2018.10.10 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|